The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. Keeping that in mind, here are three stocks under $50 to avoid and some other investments you should consider instead.
Warner Music Group (WMG)
Share Price: $26.55
Launching the careers of legendary artists like Frank Sinatra, Warner Music Group (NASDAQ: WMG) is a music company managing a diverse portfolio of artists, recordings, and music publishing services worldwide.
Why Do We Think WMG Will Underperform?
- Sales trends were unexciting over the last five years as its 8.6% annual growth was below the typical consumer discretionary company
- Free cash flow margin is not anticipated to grow over the next year
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
Warner Music Group is trading at $26.55 per share, or 15.8x forward P/E. If you’re considering WMG for your portfolio, see our FREE research report to learn more.
Tandem Diabetes (TNDM)
Share Price: $17.10
With technology that automatically adjusts insulin delivery based on continuous glucose monitoring data, Tandem Diabetes Care (NASDAQ: TNDM) develops and manufactures automated insulin delivery systems that help people with diabetes manage their blood glucose levels.
Why Do We Avoid TNDM?
- Incremental sales over the last five years were much less profitable as its earnings per share fell by 19.1% annually while its revenue grew
- Negative returns on capital show that some of its growth strategies have backfired, and its decreasing returns suggest its historical profit centers are aging
- Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned
At $17.10 per share, Tandem Diabetes trades at 19.2x forward EV-to-EBITDA. To fully understand why you should be careful with TNDM, check out our full research report (it’s free).
DXC (DXC)
Share Price: $10.05
Born from the 2017 merger of Computer Sciences Corporation and HP Enterprise's services business, DXC Technology (NYSE: DXC) is a global IT services company that helps businesses transform their technology infrastructure, applications, and operations.
Why Are We Out on DXC?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Projected sales decline of 3.8% over the next 12 months indicates demand will continue deteriorating
- Underwhelming 2.1% return on capital reflects management’s difficulties in finding profitable growth opportunities
DXC’s stock price of $10.05 implies a valuation ratio of 3.9x forward P/E. Dive into our free research report to see why there are better opportunities than DXC.
Stocks We Like More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
